ScholarIQanswers from OpenAlex

A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant

PaperCitations, authors & open-access status

A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant have?

ScholarIQcitation count

A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant has 186 citations in the OpenAlex counts ScholarIQ stores.

When was A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant published?

ScholarIQyear

A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant has 2020 year in the ScholarIQ index.

What is the open-access status of A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant?

ScholarIQoa status

A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant has green oa status in the ScholarIQ index.

What is the DOI of A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant?

ScholarIQdoi

The DOI for A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant is on the source record.

What is the PMID of A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant?

ScholarIQpmid

The PMID for A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant is on the source record.

What is the OpenAlex record for A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant?

ScholarIQopenalex

The OpenAlex for A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial